The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC

Brain metastases are more and more common among patients with non-small cell lung cancer (NSCLC). TKI therapy could provide ideal outcomes for patients harboring epidermal growth factor receptor or ALK mutations. For wild-type patients, however, survival is poor because there are few effective treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ji, Wang, Min, Xu, Shuhui, Li, Yuying, Li, Jiatong, Yu, Jinming, Zhu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152109/
https://www.ncbi.nlm.nih.gov/pubmed/35656295
http://dx.doi.org/10.3389/fphar.2022.841623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152109/
https://www.ncbi.nlm.nih.gov/pubmed/35656295
http://dx.doi.org/10.3389/fphar.2022.841623

Ejemplares similares